Chace Herndon

Chace Herndon is an experienced business development executive with a strong background in the healthcare and finance sectors. Currently serving as Vice President of Business Development at OncoLens since April 2023, Chace leads initiatives to enhance cancer care delivery through innovative technology solutions. Previously, as Vice President of Growth at BEKHealth, Chace advanced clinical trial processes by improving the accuracy of patient identification and trial feasibility through EMR data integration. Chace also held the role of Business Development Director at Bedroc, Inc., focusing on building long-term partnerships based on specific technological needs. Prior financial experience includes positions at Banes Capital Group and Shay Financial Services, where Chace facilitated fixed income products and government-backed loans. Chace's career began in pharmaceutical sales with Novo Nordisk A/S and finance as a Financial Advisor at Morgan Keegan. Chace holds a degree in Business with a concentration in Marketing from the University of Mississippi.